Banyan (BNYN) Stock Analysis & Winston Score
Banyan Corp. is a behavioral health company that runs addiction treatment centers across the United States. It provides inpatient and outpatient care for people struggling with substance use disorders and mental health conditions. The company operates multiple treatment facilities under the Banyan Treatment Centers brand, serving adult patients who need structured clinical care. Banyan earns revenue primarily by billing insurance companies, including Medicaid and private insurers, for the treatment services its facilities provide. It operates domestically and is a mid-sized player in the fragmented U.S. behavioral health market, where demand for addiction treatment has grown due to the ongoing opioid crisis. The company's 100% gross margin figure reflects a services-only model with no physical goods sold, but its deeply negative operating margin signals that overhead and operating costs significantly exceed gross profit, making a path to profitability the central challenge the business currently faces.
Winston Score: 22/100 — Weak
Weak fundamentals across most pillars.
- Quality: Mixed (10/30)
- Growth: Weak (1/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $0.00
Market Cap: $0M
Sector: Healthcare
Industry: Medical - Care Facilities
